Literature DB >> 19390347

The cardioprotective actions of leptin are lost in the Zucker obese (fa/fa) rat.

Richard A Dixon1, Sean M Davidson, Abigail M Wynne, Derek M Yellon, Christopher C T Smith.   

Abstract

Protection against myocardial ischemia-reperfusion injury, including that induced by leptin, involves activation of the reperfusion injury salvage kinase pathway and inhibition of the mitochondrial permeability transition pore. In the current study, we explored the mechanisms underlying leptin-induced cardioprotection further with reference to the leptin receptor (OB-R) and obesity. We examined hearts from Wistar and Zucker lean rats that express functional OB-R and Zucker obese (fa/fa) rats with nonfunctional OB-R. In Langendorff experiments, leptin (10 nM) caused significant reductions in infarct size in hearts from Wistar (leptin treated, 32.4% +/- 3.9% vs. control, 53.2% +/- 3.2%, P < 0.01) and Zucker lean animals (leptin treated, 25.2% +/- 3.7% vs. control, 53.9% +/- 11.3%, P < 0.01). By contrast, hearts from (fa/fa) did not exhibit significant decreases in infarct size. Leptin increased p44 and p42 phosphorylation in Wistar rat hearts by 103.9% (P < 0.05) and 157.3% (P < 0.001), respectively, and by 97.0% (P < 0.05) and 158.1% (P < 0.05) in hearts from Zucker lean rats. Akt/serine-473 phosphorylation was increased in Wistar hearts by 96.7% (P < 0.05), whereas Akt/threonine-308 phosphorylation was elevated by 43.9% (P < 0.05) in Zucker lean rat hearts. Leptin did not influence Akt or p44/42 phosphorylation in (fa/fa) animals. On leptin treatment, mitochondrial permeability transition pore opening was delayed by 43% (P < 0.01) and 30.9% (P < 0.01), respectively, in cardiomyocytes from Wistar and Zucker lean rat hearts but not in cardiomyocytes from (fa/fa). This study provides the first evidence that myocardial sensitivity to the tissue preserving actions of leptin is influenced by adiposity and OB-R status.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19390347     DOI: 10.1097/FJC.0b013e31819d6152

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  7 in total

1.  Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore.

Authors:  Christopher C T Smith; Richard A Dixon; Abigail M Wynne; Louise Theodorou; Sang-Ging Ong; Sapna Subrayan; Sean M Davidson; Derek J Hausenloy; Derek M Yellon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-23       Impact factor: 4.733

Review 2.  Cardiovascular effects of leptin.

Authors:  Gary Sweeney
Journal:  Nat Rev Cardiol       Date:  2009-12-01       Impact factor: 32.419

Review 3.  Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis.

Authors:  Sarah R Anthony; Adrienne R Guarnieri; Anamarie Gozdiff; Robert N Helsley; Albert Phillip Owens; Michael Tranter
Journal:  Clin Sci (Lond)       Date:  2019-11-29       Impact factor: 6.124

Review 4.  Stem cells in the diabetic infarcted heart.

Authors:  Carley E Glass; Pawan K Singal; Dinender K Singla
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

5.  Effect of sleeve gastrectomy, Roux-en-Y gastric bypass, and ileal transposition on myocardial ischaemia-reperfusion injury in non-obese non-diabetic rats.

Authors:  Oleg Kornyushin; Dmitry Sonin; Alexander Polozov; Vitaly Masley; Nika Bulavinova; Maria Chervyak; Maria Istomina; Daria Mukhametdinova; Alexander Neimark; Yuri Cheburkin; Yana Toropova; Kira Derkach; Alexander Shpakov; Michael Galagudza; Evgenyi Shlyakhto
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

6.  Influence of tumour necrosis factor alpha on the outcome of ischaemic postconditioning in the presence of obesity and diabetes.

Authors:  Lydia Lacerda; Lionel H Opie; Sandrine Lecour
Journal:  Exp Diabetes Res       Date:  2012-10-17

7.  Postoperative Adverse Cardiovascular Events Associated with Leptin and Adverse Age After Elective Major Non-Cardiac Surgery: An Asian Single-Center Study.

Authors:  Zheng Gu; Canlin Sun; Dong Xiang
Journal:  Med Sci Monit       Date:  2018-04-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.